+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism



Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism



Israel Journal of Medical Sciences 24(2): 75-79



The 24-h secretory pattern of hGH was studied by the aid of a continuous blood withdrawal pump in three Laron-type dwarfism (LTD) patients and compared with that in sex- and age-matched normal control subjects. It was found that the secretion of hGH was enhanced in the LTD patients, but in all three the diurnal secretory profile, as expressed by the number of pulses and the sleep-related maximal pulse, was preserved. In the younger LTD patients, women aged 19 and 21 years, the number of pulses was 9 and 7 (compared with 6 in the control subjects), the maximal hGH pulse amplitude was 164 and 280 ng/ml (compared with 135 ng/ml), the area under the curve (AUC) was 560 and 780 (compared with 268), and the average integrated concentration (A-IC) of hGH was 33.9 and 23.4 ng/ml (compared with 11.3). In the older LTD patient, a man aged 27 years, the hGH secretion was lower than that in the LTD women, but still higher than that in normal matched controls: the number of pulses was 4 (control 2), maximal pulse amplitude 67 ng/ml (control 19), AUC 231 (control 51), and A-IC 9.9 ng/ml (control 2.2). The decline in hGH secretion, which is characteristic of advancing age in normal subjects, seems to occur in LTD as well. Metabolic clearance rate (MCR) and production rate (PR) of hGH were measured in the 19-year-old female LTD patient. Her MCR was 73.4 ml/m2 per min, and her PR was 2,480 ng/ml compared with 158.3 and 839, respectively, in a normal subject. The exaggerated PR explains the elevation of plasma hGH in this syndrome and is probably the result of a lack of negative feedback due to insulin-like growth factor deficiency.

(PDF emailed within 1 workday: $29.90)

Accession: 040231814

Download citation: RISBibTeXText

PMID: 3356536


Related references

Enhanced human growth hormone pituitary secretion rate associated with somatomedin deficiency as manifested in laron type dwarfism. Pediatric Research 18(11): 1215, 1984

Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism. Oral Surgery, Oral Medicine, and Oral Pathology 66(5): 581-586, 1988

Syndrome of familial dwarfism and high plasma immuno reactive growth hormone laron type dwarfism. Paediatrician 6(2): 106-117, 1977

Carbohydrate metabolism in the syndrome of familial dwarfism and high plasma immuno reactive growth hormone laron type dwarfism. Podolsky, S. Viswanathan (ed.). Secondary Diabetes: The Spectrum Of The Diabetic Syndromes. Xxi 602p. Raven Press: New York, N.y., Usa. Illus. Maps. P363-372, 1980

Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Israel Journal of Medical Sciences 20(1): 8-11, 1984

Defective human growth hormone receptors in the liver of 2 patients with laron type dwarfism. Pediatric Research 16(10): 901, 1982

Novel splice site mutation in the growth hormone receptor gene in Turkish patients with Laron-type dwarfism. Journal of Pediatric Endocrinology & Metabolism 21(1): 47-58, 2008

Laron type dwarfism and growth hormone gene deletion. Bonne-Tamir, B And A Adam (Ed ) Genetic Diversity Among Jews: Diseases And Markers at The Dna Level; Goodman's International Conference, Israel, June 1990 Xxviii+460p Oxford University Press: New York, New York, Usa; Oxford, England, Uk Illus Maps 248-258, 1992

Comparison of growth in patients with growth hormone deletion and laron dwarfism implication on direct and indirect effects of growth hormone. Pediatric Research 25(4 PART 2): 94A, 1989

Laron type dwarfism is not due to a mutation in or near the human growth hormone gene. Pediatric Research 18(4 PART 2): 173A, 1984

Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proceedings of the National Academy of Sciences of the United States of America 84(13): 4636-4640, 1987

Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. Journal of Clinical Endocrinology and Metabolism 65(4): 814-816, 1987

Growth hormone receptor gene mutations are responsible for laron type dwarfism. Hormone Research 31(SUPPL 1): 15, 1989

Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proceedings of the National Academy of Sciences of the United States of America 86(20): 8083-8087, 1989

Laron-type dwarfism is associated with normal growth hormone and insulin-like growth factor I gene restriction patterns. Israel Journal of Medical Sciences 25(6): 342-344, 1989